{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T06:23:35Z","timestamp":1775197415400,"version":"3.50.1"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br Dent J"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1038\/sj.bdj.2017.318","type":"journal-article","created":{"date-parts":[[2017,4,7]],"date-time":"2017-04-07T09:04:35Z","timestamp":1491555875000},"page":"549-553","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["The impact of inflammatory bowel disease on oral health"],"prefix":"10.1038","volume":"222","author":[{"given":"J. S.","family":"Chandan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,7]]},"reference":[{"key":"BFsjbdj2017318_CR1","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1016\/S0140-6736(12)60026-9","volume":"380","author":"DC Baumgart","year":"2012","unstructured":"Baumgart D C, Sandborn W J, Spehlmann M et al. Crohn's disease. Lancet 2012; 380: 1590\u20131605.","journal-title":"Lancet"},{"key":"BFsjbdj2017318_CR2","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1053\/j.gastro.2004.01.063","volume":"126","author":"EV Loftus","year":"2004","unstructured":"Loftus E V . Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 2004; 126: 1504\u20131517.","journal-title":"Gastroenterology"},{"key":"BFsjbdj2017318_CR3","unstructured":"NICE. Inflammatory bowel disease | introduction. Guidance and guidelines. 2015."},{"key":"BFsjbdj2017318_CR4","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/S0140-6736(00)04309-9","volume":"357","author":"A Sawczenko","year":"2001","unstructured":"Sawczenko A, Sandhu B, Logan R et al. Prospective survey of childhood inflammatory bowel disease in the British Isles. Lancet 2001; 357: 1093\u20131094.","journal-title":"Lancet"},{"key":"BFsjbdj2017318_CR5","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1056\/NEJMra020831","volume":"347","author":"DK Podolsky","year":"2002","unstructured":"Podolsky DK . Inflammatory Bowel Disease. N Engl J Med 2002; 347: 417\u2013429.","journal-title":"N Engl J Med"},{"key":"BFsjbdj2017318_CR6","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nrgastro.2015.34","volume":"12","author":"AN Ananthakrishnan","year":"2015","unstructured":"Ananthakrishnan AN . Epidemiology and risk factors for IBD. Nat Rev Gastroenterol Hepatol 2015; 12: 205\u2013217.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"BFsjbdj2017318_CR7","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.1111\/j.1572-0241.2008.02158.x","volume":"103","author":"KT Thia","year":"2008","unstructured":"Thia K T, Loftus, Jr E V, Sandborn W J, Yang SK . An Update on the Epidemiology of Inflammatory Bowel Disease in Asia. Am J Gastroenterol 2008; 103: 3167\u20133182.","journal-title":"Am J Gastroenterol"},{"key":"BFsjbdj2017318_CR8","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1136\/gut.33.5.687","volume":"33","author":"CS Probert","year":"1992","unstructured":"Probert C S, Jayanthi V, Pinder D, Wicks A C, Mayberry J F . Epidemiological study of ulcerative proctocolitis in Indian migrants and the indigenous population of Leicestershire. Gut 1992; 33: 687\u2013693.","journal-title":"Gut"},{"key":"BFsjbdj2017318_CR9","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/35079107","volume":"411","author":"JP Hugot","year":"2001","unstructured":"Hugot J P, Chamaillard M, Zouali H et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411: 599\u2013603.","journal-title":"Nature"},{"key":"BFsjbdj2017318_CR10","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1038\/379821a0","volume":"379","author":"JP Hugot","year":"1996","unstructured":"Hugot J P, Laurent-Puig P, Gower-Rousseau C et al. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 1996; 379: 821\u2013823.","journal-title":"Nature"},{"key":"BFsjbdj2017318_CR11","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1136\/gutjnl-2011-300777","volume":"62","author":"I Cleynen","year":"2013","unstructured":"Cleynen I, Gonz\u00e1lez J R, Figueroa C et al. Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European Project. Gut 2013; 62: 1556\u20131565.","journal-title":"Gut"},{"key":"BFsjbdj2017318_CR12","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1126\/science.1135245","volume":"314","author":"RH Duerr","year":"2006","unstructured":"Duerr R H, Taylor K D, Brant S R, Rioux J D, Silverberg M S, Daly M J et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006; 314: 1461\u20131463.","journal-title":"Science"},{"key":"BFsjbdj2017318_CR13","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1136\/gut.2006.115402","volume":"56","author":"D McGovern","year":"2007","unstructured":"McGovern D, Powrie F . The IL23 axis plays a key role in the pathogenesis of IBD. Gut 2007; 56: 1333\u20131336.","journal-title":"Gut"},{"key":"BFsjbdj2017318_CR14","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1136\/bmj.284.6317.706","volume":"284","author":"AD Harries","year":"1982","unstructured":"Harries A D, Baird A, Rhodes J . Non-smoking: a feature of ulcerative colitis. Br Med J (Clin Res Ed) 1982; 284: 706.","journal-title":"Br Med J (Clin Res Ed)"},{"key":"BFsjbdj2017318_CR15","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1136\/bmj.291.6500.971-c","volume":"291","author":"G Bianchi Porro","year":"1985","unstructured":"Bianchi Porro G, Panza E . Smoking, sugar, and inflammatory bowel disease. Br Med J (Clin Res Ed) 1985; 291: 971\u2013972.","journal-title":"Br Med J (Clin Res Ed)"},{"key":"BFsjbdj2017318_CR16","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1136\/bmj.288.6419.751","volume":"288","author":"RF Logan","year":"1984","unstructured":"Logan R F, Edmond M, Somerville K W, Langman M J . Smoking and ulcerative colitis. BMJ 1984; 288: 751\u2013753.","journal-title":"BMJ"},{"key":"BFsjbdj2017318_CR17","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1111\/apt.12086","volume":"36","author":"PC Lunney","year":"2012","unstructured":"Lunney P C, Leong R W L . Review article: ulcerative colitis, smoking and nicotine therapy. Aliment Pharmacol Ther 2012; 36: 997\u20131008.","journal-title":"Aliment Pharmacol Ther"},{"key":"BFsjbdj2017318_CR18","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/0016-5085(87)91021-3","volume":"93","author":"MV Tobin","year":"1987","unstructured":"Tobin M V, Logan R F, Langman M J, McConnell R B, Gilmore I T . Cigarette smoking and inflammatory bowel disease. Gastroenterology 1987; 93: 316\u2013321.","journal-title":"Gastroenterology"},{"key":"BFsjbdj2017318_CR19","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1111\/j.1572-0241.2007.01065.x","volume":"102","author":"MC Aldhous","year":"2007","unstructured":"Aldhous M C, Drummond H E, Anderson N, Baneshi M R, Smith L A, Arnott ID R et al. Smoking habit and load influence age at diagnosis and disease extent in ulcerative colitis. Am J Gastroenterol 2007; 102: 589\u2013597.","journal-title":"Am J Gastroenterol"},{"key":"BFsjbdj2017318_CR20","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1111\/j.1572-0241.2007.01265.x","volume":"102","author":"O H\u00f6ie","year":"2007","unstructured":"H\u00f6ie O, Wolters F, Riis L, Aamodt G, Solberg C, Bernklev T et al. Ulcerative colitis: patient characteristics may predict 10yr disease recurrence in a European-wide population-based cohort. Am J Gastroenterol 2007; 102: 1692\u20131701.","journal-title":"Am J Gastroenterol"},{"key":"BFsjbdj2017318_CR21","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.3109\/00365528809090183","volume":"23","author":"EJ Boyko","year":"1988","unstructured":"Boyko E J, Perera D R, Koepsell T D, Keane E M, Inui T S . Effects of cigarette smoking on the clinical course of ulcerative colitis. Scand J Gastroenterol 1988; 23: 1147\u20131152.","journal-title":"Scand J Gastroenterol"},{"key":"BFsjbdj2017318_CR22","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.bpg.2003.12.003","volume":"18","author":"J Cosnes","year":"2004","unstructured":"Cosnes J . Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice. Best Pract Res Clin Gastroenterol 2004; 18: 481\u2013496.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"BFsjbdj2017318_CR23","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.jdent.2015.03.003","volume":"43","author":"BR Chrcanovic","year":"2015","unstructured":"Chrcanovic B R, Albrektsson T, Wennerberg A . Smoking and dental implants: A systematic review and meta-analysis. J Dent 2015; 43: 487\u2013498.","journal-title":"J Dent"},{"key":"BFsjbdj2017318_CR24","doi-asserted-by":"publisher","first-page":"79","DOI":"10.7150\/jca.7402","volume":"5","author":"E Virtanen","year":"2014","unstructured":"Virtanen E, S\u00f6der B, Andersson L C, Meurman J H, S\u00f6der P \u00d6 . History of dental infections associates with cancer in periodontally healthy subjects: a 24-year follow-up study from sweden. J Cancer 2014; 5: 79\u201385.","journal-title":"J Cancer"},{"key":"BFsjbdj2017318_CR25","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1136\/bmj.288.6414.362","volume":"288","author":"G Holdstock","year":"1984","unstructured":"Holdstock G, Savage D, Harman M, Wright R . Should patients with inflammatory bowel disease smoke? Br Med J (Clin Res Ed) 1984; 288: 362.","journal-title":"Br Med J (Clin Res Ed)"},{"key":"BFsjbdj2017318_CR26","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/0016-5085(94)90697-1","volume":"106","author":"M Cottone","year":"1994","unstructured":"Cottone M, Rosselli M, Orlando A et al. Smoking habits and recurrence in Crohn's disease. Gastroenterology 1994; 106: 643\u2013648.","journal-title":"Gastroenterology"},{"issue":"3","key":"BFsjbdj2017318_CR27","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0749-3797(18)31021-3","volume":"6","author":"Linda C. Duffy","year":"1990","unstructured":"Duffy L C, Zielezny M A, Marshall J R et al. Cigarette smoking and risk of clinical relapse in patients with Crohn's disease. Am J Prev Med; 6: 161\u2013166.","journal-title":"American Journal of Preventive Medicine"},{"key":"BFsjbdj2017318_CR28","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1111\/j.1365-2036.2005.02424.x","volume":"21","author":"GJ Johnson","year":"2005","unstructured":"Johnson G J, Cosnes J, Mansfield J C . Review article: smoking cessation as primary therapy to modify the course of Crohn's disease. Aliment Pharmacol Ther 2005; 21: 921\u2013931.","journal-title":"Aliment Pharmacol Ther"},{"key":"BFsjbdj2017318_CR29","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/00054725-200207000-00007","volume":"8","author":"IE Koutroubakis","year":"2002","unstructured":"Koutroubakis I E, Vlachonikolis I G, Kouroumalis E A . Role of appendicitis and appendectomy in the pathogenesis of ulcerative colitis: a critical review. Inflamm Bowel Dis 2002; 8: 277\u2013286.","journal-title":"Inflamm Bowel Dis"},{"key":"BFsjbdj2017318_CR30","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1136\/gut.37.5.668","volume":"37","author":"PG Godet","year":"1995","unstructured":"Godet P G, May G R, Sutherland L R . Meta-analysis of the role of oral contraceptive agents in inflammatory bowel disease. Gut 1995; 37: 668\u2013673.","journal-title":"Gut"},{"key":"BFsjbdj2017318_CR31","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/sj.ejcn.1600556","volume":"52","author":"AM Riordan","year":"1998","unstructured":"Riordan A M, Ruxton C H, Hunter JO . A review of associations between Crohn's disease and consumption of sugars. Eur J Clin Nutr 1998; 52: 229\u2013238.","journal-title":"Eur J Clin Nutr"},{"key":"BFsjbdj2017318_CR32","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1111\/j.1600-051X.2006.00942.x","volume":"33","author":"B Grossner-Schreiber","year":"2006","unstructured":"Grossner-Schreiber B, Fetter T, Hedderich J, Kocher T, Schreiber S, Jepsen S . Prevalence of dental caries and periodontal disease in patients with inflammatory bowel disease: a case-control study. J Clin Periodontol 2006; 33: 478\u2013484.","journal-title":"J Clin Periodontol"},{"key":"BFsjbdj2017318_CR33","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/0030-4220(93)90200-N","volume":"76","author":"L Halme","year":"1993","unstructured":"Halme L, Meurman J H, Laine P et al. Oral findings in patients with active or inactive Crohn's disease. Oral Surgery Oral Med Oral Pathol 1993; 76: 175\u2013181.","journal-title":"Oral Surgery Oral Med Oral Pathol"},{"issue":"Suppl","key":"BFsjbdj2017318_CR34","doi-asserted-by":"publisher","first-page":"26S","DOI":"10.14219\/jada.archive.2006.0404","volume":"137","author":"BL Mealey","year":"2006","unstructured":"Mealey B L, Statistics NC for H, Association A D et al. Periodontal disease and diabetes. A two-way street. J Am Dent Assoc 2006; 137 Suppl: 26S\u201331S.","journal-title":"J Am Dent Assoc"},{"key":"BFsjbdj2017318_CR35","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3748\/wjg.v20.i1.91","volume":"20","author":"YZ Zhang","year":"2014","unstructured":"Zhang YZ . Inflammatory bowel disease: Pathogenesis. World J Gastroenterol 2014; 20: 91.","journal-title":"World J Gastroenterol"},{"key":"BFsjbdj2017318_CR36","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/ni1092","volume":"5","author":"T Watanabe","year":"2004","unstructured":"Watanabe T, Kitani A, Murray P J, Strober W . NOD2 is a negative regulator of Toll-like receptor 2\u2013mediated T helper type 1 responses. Nat Immunol 2004; 5: 800\u2013808.","journal-title":"Nat Immunol"},{"key":"BFsjbdj2017318_CR37","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1002\/eji.201142327","volume":"42","author":"D Bernardo","year":"2012","unstructured":"Bernardo D, Vallejo-D\u00edez S, Mann E R et al. IL6 promotes immune responses in human ulcerative colitis and induces a skin-homing phenotype in the dendritic cells and Tcells they stimulate. Eur J Immunol 2012; 42: 1337\u20131353.","journal-title":"Eur J Immunol"},{"key":"BFsjbdj2017318_CR38","doi-asserted-by":"publisher","first-page":"S253","DOI":"10.1016\/S1590-8658(08)60534-4","volume":"40","author":"S Ardizzone","year":"2008","unstructured":"Ardizzone S, Puttini P S, Cassinotti A et al. Extraintestinal manifestations of inflammatory bowel disease. Dig Liver Dis 2008; 40: S253\u2013S259.","journal-title":"Dig Liver Dis"},{"key":"BFsjbdj2017318_CR39","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1542\/peds.83.5.777","volume":"83","author":"C Lenaerts","year":"1989","unstructured":"Lenaerts C, Roy C C, Vaillancourt M, Weber A M, Morin C L, Seidman E . High Incidence of Upper Gastrointestinal Tract Involvement in Children With Crohn Disease. Paediatrics 1989; 83: 777\u2013781.","journal-title":"Paediatrics"},{"key":"BFsjbdj2017318_CR40","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/ibd.20604","volume":"15","author":"FA Jose","year":"2009","unstructured":"Jose F A, Garnett E A, Vittinghoff E et al. Development of extraintestinal manifestations in paediatric patients with inflammatory bowel disease. Inflamm Bowel Dis 2009; 15: 63\u201368.","journal-title":"Inflamm Bowel Dis"},{"key":"BFsjbdj2017318_CR41","doi-asserted-by":"publisher","first-page":"8571","DOI":"10.3748\/wjg.v19.i46.8571","volume":"19","author":"KB Lankarani","year":"2013","unstructured":"Lankarani K B, Sivandzadeh G R, Hassanpour S . Oral manifestation in inflammatory bowel disease: A review. World J Gastroenterol 2013; 19: 8571\u20138579.","journal-title":"World J Gastroenterol"},{"key":"BFsjbdj2017318_CR42","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1590\/S0004-28032015000200006","volume":"52","author":"N Laranjeira","year":"2015","unstructured":"Laranjeira N, Fonseca J, Meira T, Freitas J, Valido S, Leit\u00e3o J . Oral Mucosa Lesions and Oral Symptoms in Inflammatory Bowel Disease Patients. Arq Gastroenterol 2015; 52: 105\u2013110.","journal-title":"Arq Gastroenterol"},{"key":"BFsjbdj2017318_CR43","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/apt.13217","volume":"42","author":"KH Katsanos","year":"2015","unstructured":"Katsanos K H, Torres J, Roda G, Brygo A, Delaporte E, Colombel J F . Review article: Non-malignant oral manifestations in inflammatory bowel diseases. Aliment Pharmacol Ther 2015; 42: 40\u201360.","journal-title":"Aliment Pharmacol Ther"},{"key":"BFsjbdj2017318_CR44","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1056\/NEJMicm1402919","volume":"372","author":"RM Goel","year":"2015","unstructured":"Goel R M, Hullah E . Orofacial Fistulae Associated with Crohn's Disease. N Engl J Med 2015; 372: e29.","journal-title":"N Engl J Med"},{"key":"BFsjbdj2017318_CR45","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/ibd.20958","volume":"16","author":"G Doherty","year":"2010","unstructured":"Doherty G, Kalachand R, Patchett S . Adalimumab as therapy for fistulizing orofacial Crohn's disease. Inflamm Bowel Dis 2010; 16: 184\u2013185.","journal-title":"Inflamm Bowel Dis"},{"key":"BFsjbdj2017318_CR46","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/j.1601-0825.2008.01500.x","volume":"15","author":"B Grave","year":"2009","unstructured":"Grave B, McCullough M, Wiesenfeld D . Orofacial granulomatosis \u2013 a 20-year review. Oral Dis 2009; 15: 46\u201351.","journal-title":"Oral Dis"},{"key":"BFsjbdj2017318_CR47","doi-asserted-by":"publisher","first-page":"e0134001","DOI":"10.1371\/journal.pone.0134001","volume":"10","author":"A Johannsen","year":"2015","unstructured":"Johannsen A, Fored M C, H\u00e5kansson J, Ekbom A, Gustafsson A . Consumption of dental treatment in patients with inflammatory bowel disease, a register study. PLoS One 2015; 10: e0134001.","journal-title":"PLoS One"},{"key":"BFsjbdj2017318_CR48","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s10620-010-1263-9","volume":"56","author":"S Singhal","year":"2011","unstructured":"Singhal S, Dian D, Keshavarzian A, Fogg L, Fields J Z, Farhadi A . The Role of Oral Hygiene in Inflammatory Bowel Disease. Dig Dis Sci 2011; 56: 170\u2013175.","journal-title":"Dig Dis Sci"},{"key":"BFsjbdj2017318_CR49","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1097\/MIB.0000000000000452","volume":"21","author":"V Koutsochristou","year":"2015","unstructured":"Koutsochristou V, Zellos A, Dimakou K et al. Dental Caries and Periodontal Disease in Children and Adolescents with Inflammatory Bowel Disease. Inflamm Bowel Dis 2015; 21: 1839\u20131846.","journal-title":"Inflamm Bowel Dis"},{"key":"BFsjbdj2017318_CR50","doi-asserted-by":"publisher","first-page":"e91059","DOI":"10.1371\/journal.pone.0091059","volume":"9","author":"S Szymanska","year":"2014","unstructured":"Szymanska S, L\u00f6rdal M, Rathnayake N, Gustafsson A, Johannsen A . Dental caries, prevalence and risk factors in patients with Crohn's disease. PLoS One 2014; 9: e91059.","journal-title":"PLoS One"},{"key":"BFsjbdj2017318_CR51","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/0030-4220(84)90284-6","volume":"57","author":"TP Rooney","year":"1984","unstructured":"Rooney TP . Dental caries prevalence in patients with Crohn's disease. Oral Surgery Oral Med Oral Pathol 1984; 57: 623\u2013624.","journal-title":"Oral Surgery Oral Med Oral Pathol"},{"key":"BFsjbdj2017318_CR52","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/0030-4220(89)90356-3","volume":"67","author":"B Sundh","year":"1989","unstructured":"Sundh B, Emilson C G . Salivary and microbial conditions and dental health in patients with Crohn's disease: a 3year study. Oral Surg Oral Med Oral Pathol 1989; 67: 286\u2013290.","journal-title":"Oral Surg Oral Med Oral Pathol"},{"issue":"3","key":"BFsjbdj2017318_CR53","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/jre.12422","volume":"52","author":"K. Agossa","year":"2016","unstructured":"Agossa K, Dendooven A, Dubuquoy L, Gower-Rousseau C, Delcourt-Debruyne E, Capron M . Periodontal manifestations of inflammatory bowel disease: emerging epidemiologic and biologic evidence. J Periodontal Res 2016; DOI: 10.1111\/jre.12422.","journal-title":"Journal of Periodontal Research"},{"key":"BFsjbdj2017318_CR54","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1111\/j.1600-051X.2006.00942.x","volume":"33","author":"B Gr\u00f6ssner-Schreiber","year":"2006","unstructured":"Gr\u00f6ssner-Schreiber B, Fetter T, Hedderich J, Kocher T, Schreiber S, Jepsen S . Prevalence of dental caries and periodontal disease in patients with inflammatory bowel disease: a case-control study. J Clin Periodontol 2006; 33: 478\u2013484.","journal-title":"J Clin Periodontol"},{"key":"BFsjbdj2017318_CR55","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/j.1600-051X.2008.01231.x","volume":"35","author":"F Brito","year":"2008","unstructured":"Brito F, de Barros F C, Zaltman C et al. Prevalence of periodontitis and DMFT index in patients with Crohn's disease and ulcerative colitis. J Clin Periodontol 2008; 35: 555\u2013560.","journal-title":"J Clin Periodontol"},{"key":"BFsjbdj2017318_CR56","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1097\/01.MIB.0000438356.84263.3b","volume":"19","author":"SR Vavricka","year":"2013","unstructured":"Vavricka S R, Manser C N, Hediger S et al. Periodontitis and gingivitis in inflammatory bowel disease: a case-control study. Inflamm Bowel Dis 2013; 19: 2768\u20132777.","journal-title":"Inflamm Bowel Dis"},{"key":"BFsjbdj2017318_CR57","doi-asserted-by":"publisher","first-page":"5655","DOI":"10.3748\/wjg.v22.i25.5655","volume":"22","author":"M Muhvi\u0107-Urek","year":"2016","unstructured":"Muhvi\u0107-Urek M, Tomac-Stojmenovi\u0107 M, Mijandru\u0161i\u0107-Sin\u0107i\u0107 B. Oral pathology in inflammatory bowel disease 2016 Inflammatory Bowel Disease: Global view. World J Gastroenterol 2016; 22: 5655\u20135667.","journal-title":"World J Gastroenterol"},{"key":"BFsjbdj2017318_CR58","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.otc.2010.09.006","volume":"44","author":"NM Islam","year":"2011","unstructured":"Islam N M, Bhattacharyya I, Cohen D M . Common oral manifestations of systemic disease. Otolaryngol Clin North Am 2011; 44: 161\u2013182.","journal-title":"Otolaryngol Clin North Am"},{"key":"BFsjbdj2017318_CR59","unstructured":"NICE. Ulcerative colitis overview \u2013 NICE Pathways. 2016. Available online at https:\/\/pathways.nice.org.uk\/pathways\/ulcerative-colitis#content=view-node%3Anodes-maintaining-remission (accessed March 2017)."},{"key":"BFsjbdj2017318_CR60","unstructured":"NICE. Crohn's disease overview \u2013 NICE Pathways. 2016. Available online at https:\/\/pathways.nice.org.uk\/pathways\/crohns-disease (accessed March 2017)."},{"key":"BFsjbdj2017318_CR61","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1056\/NEJM198012253032602","volume":"303","author":"U Klotz","year":"1980","unstructured":"Klotz U, Maier K, Fischer C, Heinkel K . Therapeutic Efficacy of Sulphasalazine and Its Metabolites in Patients with Ulcerative Colitis and Crohn's Disease. N Engl J Med 1980; 303: 1499\u20131502.","journal-title":"N Engl J Med"},{"key":"BFsjbdj2017318_CR62","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/BF01296907","volume":"28","author":"SL Taffet","year":"1983","unstructured":"Taffet S L, Das K M . Sulphasalazine. Dig Dis Sci 1983; 28: 833\u2013842.","journal-title":"Dig Dis Sci"},{"key":"BFsjbdj2017318_CR63","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/BF02333012","volume":"43","author":"M Keisu","year":"1992","unstructured":"Keisu M, Ekman E . Sulphasalazine associated agranulocytosis in Sweden 1972\u20131989. Eur J Clin Pharmacol 1992; 43: 215\u2013218.","journal-title":"Eur J Clin Pharmacol"},{"key":"BFsjbdj2017318_CR64","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.immuni.2006.06.018","volume":"25","author":"T Watanabe","year":"2006","unstructured":"Watanabe T . Nucleotide binding oligomerization domain 2 deficiency leads to dysregulated TLR2 signalling and induction of antigen-specific colitis. Immunity 2006; 25: 473\u2013485.","journal-title":"Immunity"},{"key":"BFsjbdj2017318_CR65","first-page":"634","volume":"18","author":"RW Marcus","year":"1991","unstructured":"Marcus R W . Sulphasalazine induced taste disturbances. J Rheumatol 1991; 18: 634\u2013635.","journal-title":"J Rheumatol"},{"key":"BFsjbdj2017318_CR66","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1080\/003655298750027290","volume":"225","author":"WJ Sandborn","year":"1998","unstructured":"Sandborn W J . Azathioprine: state of the art in inflammatory bowel disease. Scand J Gastroenterol Suppl 1998; 225: 92\u201399.","journal-title":"Scand J Gastroenterol Suppl"},{"key":"BFsjbdj2017318_CR67","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/0022-4804(80)90169-9","volume":"29","author":"R Pollak","year":"1980","unstructured":"Pollak R, Nishikawa R A, Mozes M F, Jonasson O . Azathioprine-induced leukopenia\u2014Clinical significance in renal transplantation. J Surg Res 1980; 29: 258\u2013264.","journal-title":"J Surg Res"},{"key":"BFsjbdj2017318_CR68","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1136\/gut.2004.049460","volume":"54","author":"A Kandiel","year":"2005","unstructured":"Kandiel A, Fraser A G, Korelitz B I, Brensinger C, Lewis J D . Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6mercaptopurine. Gut 2005; 54: 1121\u20131125.","journal-title":"Gut"},{"key":"BFsjbdj2017318_CR69","doi-asserted-by":"crossref","unstructured":"Kobler P, Borcic J, Zore I F, Nola M, Sertic D . Primary non-Hodgkin's lymphoma of the oral cavity. 2005; 10.1016\/j.ooe.2004.10.002.","DOI":"10.1016\/j.ooe.2004.10.002"},{"key":"BFsjbdj2017318_CR70","doi-asserted-by":"publisher","first-page":"113","DOI":"10.4292\/wjgpt.v5.i3.113","volume":"5","author":"A Swaminath","year":"2014","unstructured":"Swaminath A, Taunk R, Lawlor G . Use of methotrexate in inflammatory bowel disease in 2014: A User's Guide. World J Gastrointest Pharmacol Ther 2014; 5: 113\u2013121.","journal-title":"World J Gastrointest Pharmacol Ther"},{"key":"BFsjbdj2017318_CR71","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1007\/s001050050979","volume":"50","author":"J Bauer","year":"1999","unstructured":"Bauer J, Fartasch M, Schuler G, Schell H . [Ulcerative stomatitis as clinical clue to inadvertent methotrexate overdose]. Der Hautarzt; Zeitschrift fu\u00a8r Dermatologie, Venerol und verwandte Gebiete 1999; 50: 670\u2013673.","journal-title":"Der Hautarzt; Zeitschrift fu\u00a8r Dermatologie, Venerol und verwandte Gebiete"},{"key":"BFsjbdj2017318_CR72","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/adj.12235","volume":"60","author":"N Horie","year":"2015","unstructured":"Horie N, Kawano R, Kaneko T, Shimoyama T . Methotrexate-related lymphoproliferative disorder arising in the gingiva of a patient with rheumatoid arthritis. Aust Dent J 2015; 60: 408\u2013411.","journal-title":"Aust Dent J"},{"key":"BFsjbdj2017318_CR73","first-page":"2237","volume":"6","author":"M Ishida","year":"2013","unstructured":"Ishida M, Hodohara K, Yoshii M et al. Case Report Methotrexate-related Epstein-Barr virus-associated lymphoproliferative disorder occurring in the gingiva of a patient with rheumatoid arthritis. Int J Clin Exp Pathol 2013; 6: 2237\u20132241.","journal-title":"Int J Clin Exp Pathol"},{"key":"BFsjbdj2017318_CR74","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1056\/NEJMoa011110","volume":"345","author":"J Keane","year":"2001","unstructured":"Keane J, Gershon S, Wise R P et al. Tuberculosis Associated with Infliximab, a Tumour Necrosis Factor \u03b1\u2013Neutralizing Agent. N Engl J Med 2001; 345: 1098\u20131104.","journal-title":"N Engl J Med"},{"key":"BFsjbdj2017318_CR75","first-page":"1153","volume":"168","author":"R Long","year":"2003","unstructured":"Long R, Gardam M . Tumour necrosis factor-alpha inhibitors and the reactivation of latent tuberculosis infection. CMAJ 2003; 168: 1153\u20131156.","journal-title":"CMAJ"},{"key":"BFsjbdj2017318_CR76","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1136\/gut.47.3.436","volume":"47","author":"DH Casson","year":"2000","unstructured":"Casson D H, Eltumi M, Tomlin S, Walker-Smith J A, Murch S H . Topical tacrolimus may be effective in the treatment of oral and perineal Crohn's disease. Gut 2000; 47: 436\u2013440.","journal-title":"Gut"},{"key":"BFsjbdj2017318_CR77","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/sj.ebd.6400872","volume":"13","author":"AV Keenan","year":"2012","unstructured":"Keenan AV . Promising results for dexamethasome ointment for treatment of recurrent aphthae. Evid Based Dent 2012; 13: 75\u201375.","journal-title":"Evid Based Dent"},{"key":"BFsjbdj2017318_CR78","first-page":"451","volume":"79","author":"AJ Williams","year":"1991","unstructured":"Williams A J, Wray D, Ferguson A . The clinical entity of orofacial Crohn's disease. Q J Med 1991; 79: 451\u2013458.","journal-title":"Q J Med"},{"key":"BFsjbdj2017318_CR79","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/j.1600-0714.2007.00430.x","volume":"36","author":"KS Staines","year":"2007","unstructured":"Staines K S, Green R, Felix D H . The management of fistulizing oral Crohn's disease with infliximab. J Oral Pathol Med 2007; 36: 444\u2013446.","journal-title":"J Oral Pathol Med"},{"key":"BFsjbdj2017318_CR80","first-page":"604","volume":"11","author":"JL Peix","year":"1987","unstructured":"Peix J L, Moulin G, Evreux M, Berger N, Magis M . [Bucco-pharyngeal and esophageal localizations in Crohn's disease]. Gastroenterol Clin Biol 1987; 11: 604\u2013606.","journal-title":"Gastroenterol Clin Biol"},{"key":"BFsjbdj2017318_CR81","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/0030-4220(84)90308-6","volume":"57","author":"KD Hay","year":"1984","unstructured":"Hay K D, Reade P C . The use of an elimination diet in the treatment of recurrent aphthous ulceration of the oral cavity. Oral Surgery Oral Med Oral Pathol 1984; 57: 504\u2013507.","journal-title":"Oral Surgery Oral Med Oral Pathol"},{"key":"BFsjbdj2017318_CR82","first-page":"14","volume":"8","author":"S K","year":"2014","unstructured":"K S, B S, Palaneeswari M S, Devi A J M . Significance of ferritin in recurrent oral ulceration. J Clin Diagn Res 2014; 8: 14\u201315.","journal-title":"J Clin Diagn Res"},{"key":"BFsjbdj2017318_CR83","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1067\/mpd.2001.113008","volume":"138","author":"S Pittock","year":"2001","unstructured":"Pittock S, Drumm B, Fleming P et al. The oral cavity in Crohn's disease. J Paediatr 2001; 138: 767\u2013771.","journal-title":"J Paediatr"}],"container-title":["British Dental Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/sj.bdj.2017.318.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/sj.bdj.2017.318","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/sj.bdj.2017.318","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/sj.bdj.2017.318.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T22:30:35Z","timestamp":1684621835000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/sj.bdj.2017.318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":83,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["BFsjbdj2017318"],"URL":"https:\/\/doi.org\/10.1038\/sj.bdj.2017.318","relation":{},"ISSN":["0007-0610","1476-5373"],"issn-type":[{"value":"0007-0610","type":"print"},{"value":"1476-5373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"30 January 2017","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2017","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}